ClinVar Miner

Submissions for variant NM_000540.3(RYR1):c.4766A>C (p.Gln1589Pro)

gnomAD frequency: 0.00001  dbSNP: rs780420237
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000655499 SCV000777430 uncertain significance RYR1-related disorder 2022-07-24 criteria provided, single submitter clinical testing This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 1589 of the RYR1 protein (p.Gln1589Pro). This variant is present in population databases (rs780420237, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of RYR1-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 544377). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
PreventionGenetics, part of Exact Sciences RCV000721555 SCV000852643 uncertain significance not provided 2016-08-26 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002477466 SCV002779118 uncertain significance Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome 2021-09-10 criteria provided, single submitter clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV002534229 SCV003761230 uncertain significance RYR1-related myopathy 2023-01-25 criteria provided, single submitter curation The heterozygous p.Gln1589Pro variant in RYR1 was identified by our study, in the compound heterozygous state with a variant of uncertain significance (NC_000019.10:g.38587339G>T), in one individual with central core disease. Familial segregation analysis revealed that this variant was in trans with another variant of uncertain significance (NC_000019.10:g.38587339G>T). The p.Gln1589Pro variant in RYR1 has not been previously reported in the literature in individuals with RYR1-related myopathy but has been identified in 0.001% (1/68664) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs780420237). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 544377) and has been interpreted as a variant of uncertain significance by Invitae and Prevention Genetics. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Gln1589Pro variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, PP3 (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.